Back to search

Boston University

Serology as a predictor of mucosal recovery in children with celiac disease on a gluten-free diet

Abstract

dc:description.abstract

BACKGROUND: Research continues to be done to assess if serology markers are predictors of mucosal recovery in individuals with celiac disease (CD), eliminating the need for additional biopsies after treatment with a gluten-free diet (GFD). Aim: The objective of this study is to determine if the anti-deamidated gliadin protein (DGP) immunoglobulin G (IgG) serology test can predict mucosal recovery at the time of a repeat endoscopy with duodenal biopsies in pediatric subjects. METHODS: A total of 176 subjects were included in this study, ages 2 to 21 years old, diagnosed with CD, and having undergone diagnostic and repeat duodenal biopsies through esophagogastroduodenoscopy (EGD). Subjects provided blood, urine, and tissue samples as well as completed questionnaires. ELISA QUANTA Lite Rh-tTG IgA on the BioFlash platform was used for the determination of IgG antibodies against DGP epitopes in subjects’ serum. RESULTS: Of the 176 subjects included, 23 subjects (13%) had persistent enteropathy (PE) defined as a Marsh score of 3. DGP-IgG was elevated in 7 out of 23 (30%) of these subjects. 153 CD subjects were in remission, defined as having Marsh scores of 0 through 2 and five positive DGP-IgG values (33%). Overall, the positive predictive value (PPV) of DGP-IgG for mucosal damage and a positive DGP-IgG value was 58% and the negative predictive value (NPV) was 91%. There was a statistically significant elevation in DGP-IgG serum values for subjects with a Marsh score of 2 and 3 compared to subjects with a Marsh score of 0 (p<0.05). Additionally, there was a statistically significant difference in DGP-IgG serum values between those with CD in remission vs. those with persistent enteropathy (p=0.02). Lastly, DGP-IgG values at diagnosis versus at follow-up were compared for 24 subjects, with a statistically significant drop in DGP-IgG values for the remission group at follow-up (p<0.01). CONCLUSION: Subjects with PE had elevated DGP-IgG levels at follow-up compared to the remission group. DGP-IgG values were relatively reliable indicators of mucosal healing for subjects in remission, although they were not completely predictive of mucosal damage in those with PE at the time of a repeat EGD. These findings suggest that DGP-IgG is a useful serology test to use at the time of follow-up and that additional pairings or varieties of tests along with DGP-IgG may be very useful in predicting mucosal recovery over time on a GFD. Keywords: celiac, serology, pediatric, duodenal, remission, anti-DGP (IgG)

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bohn, Marianne
Advisor dc:contributor.advisor
  • Browning, Jeffrey
ORCID dc:identifier.orcid

Subjects

dc:subject × 8

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/51287

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Bohn, Marianne. Serology as a predictor of mucosal recovery in children with celiac disease on a gluten-free diet. masters thesis, Boston University, 2024. https://hdl.handle.net/2144/51287